Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination
NCT ID: NCT02003508
Last Updated: 2020-03-06
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
345 participants
OBSERVATIONAL
2014-01-31
2017-12-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)
NCT03000933
Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)
NCT04199689
Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)
NCT00365378
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)
NCT01651949
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
NCT01984697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-school based vaccination program (not vaccine eligible)
Young (17-19 years) men who were not eligible for school based vaccination due to their age at the time of the programs roll out.
No interventions assigned to this group
Post-school based vaccination program (vaccine eligible)
Young men (17-19 years) who were eligible for school based vaccination due to their age at the time of the programs roll out.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 17 to 19
* Able to complete study requirements
* Residing in Australia from 12 years of age
Exclusion Criteria
17 Years
19 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck Sharp & Dohme LLC
INDUSTRY
The Alfred
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marcus Chen
Adjunct Associate Professor Central Clinical School and Medical Services Manager Melbourne Sexual Health Centre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcus Y Chen, PhD
Role: PRINCIPAL_INVESTIGATOR
Melbourne Sexual Health Centre Alfred Health and Central Clinical School Monash University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Melbourne Sexual Health Centre
Melbourne, Victoria, Australia
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IISP50939
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.